Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation

Thomas M. Attard, Anil Dhawan, Stuart S. Kaufman, Dean S Collier, Alan Norman Langnas

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We report four children with advanced liver disease awaiting liver transplantation who developed moderately severe hypercalcemia (range: 1.65-2.40 mmol/L) while receiving total parenteral nutrition. Hypercalcemia had been unresponsive to cessation of calcium intake and therapy with loop diuretics and calcitonin. One or two intravenous doses of disodium pamidronate (35-50 mg/m2) resulted in normalization of plasma calcium concentration within 2-4 d in all four children. Pamidronate may be useful for children with hypercalcemia associated with liver disease.

Original languageEnglish (US)
Pages (from-to)157-159
Number of pages3
JournalPediatric Transplantation
Volume2
Issue number2
StatePublished - Dec 1 1998

Fingerprint

pamidronate
Hypercalcemia
Liver Transplantation
Liver Diseases
Calcium
Sodium Potassium Chloride Symporter Inhibitors
Total Parenteral Nutrition
Calcitonin

Keywords

  • Bisphospnonate pamidronate
  • Child
  • Hypercalcemia
  • Liver transplantation
  • Short bowel syndrome
  • Total parenteral nutrition

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation. / Attard, Thomas M.; Dhawan, Anil; Kaufman, Stuart S.; Collier, Dean S; Langnas, Alan Norman.

In: Pediatric Transplantation, Vol. 2, No. 2, 01.12.1998, p. 157-159.

Research output: Contribution to journalArticle

@article{e7f0c8bad6de4483a143644c99ac2b95,
title = "Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation",
abstract = "We report four children with advanced liver disease awaiting liver transplantation who developed moderately severe hypercalcemia (range: 1.65-2.40 mmol/L) while receiving total parenteral nutrition. Hypercalcemia had been unresponsive to cessation of calcium intake and therapy with loop diuretics and calcitonin. One or two intravenous doses of disodium pamidronate (35-50 mg/m2) resulted in normalization of plasma calcium concentration within 2-4 d in all four children. Pamidronate may be useful for children with hypercalcemia associated with liver disease.",
keywords = "Bisphospnonate pamidronate, Child, Hypercalcemia, Liver transplantation, Short bowel syndrome, Total parenteral nutrition",
author = "Attard, {Thomas M.} and Anil Dhawan and Kaufman, {Stuart S.} and Collier, {Dean S} and Langnas, {Alan Norman}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "2",
pages = "157--159",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation

AU - Attard, Thomas M.

AU - Dhawan, Anil

AU - Kaufman, Stuart S.

AU - Collier, Dean S

AU - Langnas, Alan Norman

PY - 1998/12/1

Y1 - 1998/12/1

N2 - We report four children with advanced liver disease awaiting liver transplantation who developed moderately severe hypercalcemia (range: 1.65-2.40 mmol/L) while receiving total parenteral nutrition. Hypercalcemia had been unresponsive to cessation of calcium intake and therapy with loop diuretics and calcitonin. One or two intravenous doses of disodium pamidronate (35-50 mg/m2) resulted in normalization of plasma calcium concentration within 2-4 d in all four children. Pamidronate may be useful for children with hypercalcemia associated with liver disease.

AB - We report four children with advanced liver disease awaiting liver transplantation who developed moderately severe hypercalcemia (range: 1.65-2.40 mmol/L) while receiving total parenteral nutrition. Hypercalcemia had been unresponsive to cessation of calcium intake and therapy with loop diuretics and calcitonin. One or two intravenous doses of disodium pamidronate (35-50 mg/m2) resulted in normalization of plasma calcium concentration within 2-4 d in all four children. Pamidronate may be useful for children with hypercalcemia associated with liver disease.

KW - Bisphospnonate pamidronate

KW - Child

KW - Hypercalcemia

KW - Liver transplantation

KW - Short bowel syndrome

KW - Total parenteral nutrition

UR - http://www.scopus.com/inward/record.url?scp=0032057603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032057603&partnerID=8YFLogxK

M3 - Article

C2 - 10082449

AN - SCOPUS:0032057603

VL - 2

SP - 157

EP - 159

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 2

ER -